Search research articles
Contact Us
Filters
Showing results (181-190 of 483) with videos related to
Page
of 49
Sort By:
International Journal of Molecular Sciences
|
January 29, 2016
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites
Gabriel Rinnerthaler, Hubert Hackl, Simon Peter Gampenrieder, et al.
BMC Cancer
|
October 18, 2015
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
Thomas Melchardt, Clemens Hufnagl, Teresa Magnes, et al.
BMC Cancer
|
August 11, 2012
Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group
Anke Reinacher-Schick, Karsten Schulmann, Dominik P Modest, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 26, 2008
Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13
Olaf Merkel, Christoph Heyder, Daniela Asslaber, et al.
Oncology Letters
|
January 23, 2020
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer
Clemens Hufnagl, Michael Leisch, Lukas Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2018
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation
Daniela Asslaber, Nathalie Wacht, Michael Leisch, et al.
Onkologie
|
May 18, 2011
Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe
Richard Greil, Simona Borštnar, Katarína Petráková, et al.
European Journal of Radiology
|
April 29, 2023
Prognostic value of [<sup>18</sup>F]FDG PET/CT on treatment response and progression-free survival of gastroesophageal cancer patients undergoing perioperative FLOT chemotherapy
Seyed Ali Mirshahvalad, Seyedeh Sara Seyedinia, Florian Huemer, et al.
Anticancer Research
|
October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3
Ewald Wöll, Josef Thaler, Felix Keil, et al.
Annals of Surgery
|
May 15, 2019
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial
Florian Fitzal, Vesna Bjelic-Radisic, Michael Knauer, et al.
Page
of 49
Search research articles
Search
Showing results (181-190 of 483) with videos related to
Sort By:
Page
of 49
International Journal of Molecular Sciences
|
January 29, 2016
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites
Gabriel Rinnerthaler, Hubert Hackl, Simon Peter Gampenrieder, et al.
BMC Cancer
|
October 18, 2015
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
Thomas Melchardt, Clemens Hufnagl, Teresa Magnes, et al.
BMC Cancer
|
August 11, 2012
Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group
Anke Reinacher-Schick, Karsten Schulmann, Dominik P Modest, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
February 26, 2008
Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13
Olaf Merkel, Christoph Heyder, Daniela Asslaber, et al.
Oncology Letters
|
January 23, 2020
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer
Clemens Hufnagl, Michael Leisch, Lukas Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2018
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation
Daniela Asslaber, Nathalie Wacht, Michael Leisch, et al.
Onkologie
|
May 18, 2011
Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe
Richard Greil, Simona Borštnar, Katarína Petráková, et al.
European Journal of Radiology
|
April 29, 2023
Prognostic value of [<sup>18</sup>F]FDG PET/CT on treatment response and progression-free survival of gastroesophageal cancer patients undergoing perioperative FLOT chemotherapy
Seyed Ali Mirshahvalad, Seyedeh Sara Seyedinia, Florian Huemer, et al.
Anticancer Research
|
October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3
Ewald Wöll, Josef Thaler, Felix Keil, et al.
Annals of Surgery
|
May 15, 2019
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial
Florian Fitzal, Vesna Bjelic-Radisic, Michael Knauer, et al.
Page
of 49